These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 2530459)

  • 1. Cerebral amyloidosis, ageing and Alzheimer's disease; a contribution from studies on Down's syndrome.
    Mann DM
    Neurobiol Aging; 1989; 10(5):397-9; discussion 412-4. PubMed ID: 2530459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease.
    Hof PR; Bouras C; Perl DP; Sparks DL; Mehta N; Morrison JH
    Arch Neurol; 1995 Apr; 52(4):379-91. PubMed ID: 7710374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome.
    Ikeda S; Allsop D; Glenner GG
    Prog Clin Biol Res; 1989; 317():313-23. PubMed ID: 2532370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein.
    Coria F; Castaño EM; Frangione B
    Am J Pathol; 1987 Dec; 129(3):422-8. PubMed ID: 3322021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
    Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
    N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis.
    Coria F; Castaño E; Prelli F; Larrondo-Lillo M; van Duinen S; Shelanski ML; Frangione B
    Lab Invest; 1988 Apr; 58(4):454-8. PubMed ID: 2965774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of amyloid (A4) protein deposits within the cerebral and cerebellar cortex in Down's syndrome and Alzheimer's disease.
    Mann DM; Jones D; Prinja D; Purkiss MS
    Acta Neuropathol; 1990; 80(3):318-27. PubMed ID: 1698007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral extracellular preamyloid deposits in Alzheimer's disease, Down syndrome and nondemented elderly individuals.
    Tagliavini F; Giaccone G; Linoli G; Frangione B; Bugiani O
    Prog Clin Biol Res; 1989; 317():1001-5. PubMed ID: 2532368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesis.
    Griffin WS; Sheng JG; McKenzie JE; Royston MC; Gentleman SM; Brumback RA; Cork LC; Del Bigio MR; Roberts GW; Mrak RE
    Neurobiol Aging; 1998; 19(5):401-5. PubMed ID: 9880042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease.
    Joachim CL; Mori H; Selkoe DJ
    Nature; 1989 Sep; 341(6239):226-30. PubMed ID: 2528696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of s100beta in Down's syndrome: correlation with patient age and with beta-amyloid deposition.
    Royston MC; McKenzie JE; Gentleman SM; Sheng JG; Mann DM; Griffin WS; Mrak RE
    Neuropathol Appl Neurobiol; 1999 Oct; 25(5):387-93. PubMed ID: 10564528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein.
    Glenner GG; Wong CW
    Biochem Biophys Res Commun; 1984 Aug; 122(3):1131-5. PubMed ID: 6236805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid-β and Astrocytes Interplay in Amyloid-β Related Disorders.
    Batarseh YS; Duong QV; Mousa YM; Al Rihani SB; Elfakhri K; Kaddoumi A
    Int J Mol Sci; 2016 Mar; 17(3):338. PubMed ID: 26959008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructure of amyloid fibrils in Alzheimer's disease and Down's syndrome.
    Miyakawa T; Watanabe K; Katsuragi S
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 52(2):99-106. PubMed ID: 2878535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathological changes in Down's syndrome hippocampal formation. Effect of age and apolipoprotein E genotype.
    Hyman BT; West HL; Rebeck GW; Lai F; Mann DM
    Arch Neurol; 1995 Apr; 52(4):373-8. PubMed ID: 7710373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal RNA oxidation in Alzheimer's disease and Down's syndrome.
    Nunomura A; Perry G; Hirai K; Aliev G; Takeda A; Chiba S; Smith MA
    Ann N Y Acad Sci; 1999; 893():362-4. PubMed ID: 10672267
    [No Abstract]   [Full Text] [Related]  

  • 17. Deposition of apolipoproteins E and J in senile plaques is topographically determined in both Alzheimer's disease and Down's syndrome brain.
    Kida E; Choi-Miura NH; Wisniewski KE
    Brain Res; 1995 Jul; 685(1-2):211-6. PubMed ID: 7583250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease and Down's syndrome.
    Mann DM
    Histopathology; 1988 Aug; 13(2):125-37. PubMed ID: 2971602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of non-fibrillar amyloid beta protein in skin biopsies of Alzheimer's disease (AD), Down's syndrome and non-AD normal persons.
    Wen GY; Wisniewski HM; Blondal H; Benedikz E; Frey H; Pirttila T; Rudelli R; Kim KS
    Acta Neuropathol; 1994; 88(3):201-6. PubMed ID: 7810290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The distribution of amyloid plaques in the cerebellum and brain stem in Down's syndrome and Alzheimer's disease: a light microscopical analysis.
    Cole G; Neal JW; Singhrao SK; Jasani B; Newman GR
    Acta Neuropathol; 1993; 85(5):542-52. PubMed ID: 8493862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.